Sunjin Beauty ScienceLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sunjin Beauty ScienceLtd has a total shareholder equity of ₩78.5B and total debt of ₩38.6B, which brings its debt-to-equity ratio to 49.2%. Its total assets and total liabilities are ₩134.2B and ₩55.7B respectively. Sunjin Beauty ScienceLtd's EBIT is ₩11.1B making its interest coverage ratio 7.3. It has cash and short-term investments of ₩12.2B.
Key information
49.2%
Debt to equity ratio
₩38.60b
Debt
| Interest coverage ratio | 7.3x |
| Cash | ₩12.19b |
| Equity | ₩78.47b |
| Total liabilities | ₩55.72b |
| Total assets | ₩134.19b |
Recent financial health updates
Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance Sheet
Nov 04
Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?
Jul 27Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?
Apr 23Recent updates
Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance Sheet
Nov 04Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) 30% Cheaper Price Remains In Tune With Earnings
Aug 04Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?
Jul 27What Does Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Share Price Indicate?
Jul 04After Leaping 94% Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Shares Are Not Flying Under The Radar
Jun 19Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To Continue
Jun 06Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?
Apr 23Financial Position Analysis
Short Term Liabilities: A086710's short term assets (₩46.8B) exceed its short term liabilities (₩30.2B).
Long Term Liabilities: A086710's short term assets (₩46.8B) exceed its long term liabilities (₩25.5B).
Debt to Equity History and Analysis
Debt Level: A086710's net debt to equity ratio (33.7%) is considered satisfactory.
Reducing Debt: A086710's debt to equity ratio has reduced from 123.2% to 49.2% over the past 5 years.
Debt Coverage: A086710's debt is well covered by operating cash flow (26.5%).
Interest Coverage: A086710's interest payments on its debt are well covered by EBIT (7.3x coverage).